“Receiving the Rare Pediatric Disease Designation for NEO100 is a crucial step forward in our mission to develop effective treatments for children facing diffuse high-grade gliomas,” said Dr. Thomas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results